Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Guillén Navarro María José"'
Autor:
Martínez-Díez, Marta, Guillén-Navarro, María José, Pera, Benet, Bouchet, Benjamin Pierre, Martínez-Leal, Juan Fernando, Barasoain, Isabel, Cuevas, Carmen, Andreu, Jose M., García-Fernández, Luis Francisco, Díaz, J. Fernando, Avilés, Pablo, Galmarini, Carlos M.
Publikováno v:
In Biochemical Pharmacology 1 April 2014 88(3):291-302
Autor:
Leal, Juan F.M., García-Hernández, Verónica, Moneo, Victoria, Domingo, Alberto, Bueren-Calabuig, Juan Antonio, Negri, Ana, Gago, Federico, Guillén-Navarro, María José, Avilés, Pablo, Cuevas, Carmen, García-Fernández, Luis Francisco, Galmarini, Carlos María
Publikováno v:
In Biochemical Pharmacology 2009 78(2):162-170
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Guillén Navarro María José, Matt Harlow, Patrick J. Grohar, Zachary Madaj, Joseph T. Roland, Pablo M. Aviles, Ben K. Johnson, Mary E. Winn, Susan M. Kitchen-Goosen, Matthew K. Easton, Elissa Boguslawski, Lisa Turner, Maurizio D'Incalci, Megan J. Bowman, Galen Hostetter, Carlos M. Galmarini, Nichole Maloney
Publikováno v:
Cancer research. 76(22)
There is a great need to develop novel approaches to target oncogenic transcription factors with small molecules. Ewing sarcoma is emblematic of this need, as it depends on the continued activity of the EWS-FLI1 transcription factor to maintain the m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::64394bab1f51605390b7a5e32ee2f21b
https://pubmed.ncbi.nlm.nih.gov/27697767
https://pubmed.ncbi.nlm.nih.gov/27697767
Autor:
Anderson Peck, Guillén Navarro María José, Zachary Madaj, Carlos M. Galmarini, Pablo Aviles, Patrick J. Grohar, Elissa Boguslawski, Matt Harlow
Publikováno v:
Cancer Research. 77:LB-047
BACKGROUND: Ewing sarcoma (ES) is a pediatric malignancy characterized by the EWS-FLI1 transcription factor. ES tumors require the continuous transcriptional activity of EWS-FLI1 for the oncogenic phenotype, regardless of fusion type, which makes EWS
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c44b7d2a3e716762aeacfa9f74815d10
https://doi.org/10.1158/1538-7445.am2017-lb-047
https://doi.org/10.1158/1538-7445.am2017-lb-047
Autor:
Patrick J. Grohar, Galen Hostetter, Guillén Navarro María José, Pablo Aviles, Carlos M. Galmarini, Matthew K. Easton, Lisa Turner, Matt Harlow
Publikováno v:
Cancer Research. 76:LB-177
BACKGROUND: Ewing sarcoma is a bone and soft tissue sarcoma characterized by fusion of the wild-type EWSR1 and FLI1 genes, which creates a constitutively activated transcription factor, EWS/FLI1. Ewing sarcoma cells are dependent on the continued act
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a5c1451ecd9748d93a386377eb3c44bb
https://doi.org/10.1158/1538-7445.am2016-lb-177
https://doi.org/10.1158/1538-7445.am2016-lb-177
Autor:
Matt Harlow, Carlos M. Galmarini, Guillén Navarro María José, Nichole Maloney, Patrick J. Grohar, Maurizio D'Incalci, Avilés Marín Pablo Manuel
Publikováno v:
Cancer Research. 74:3962-3962
BACKGROUND: Ewing sarcoma is a pediatric malignancy characterized by the fusion of the EWSR1 and FLI1 genes, which creates a constitutively activated transcription factor, EWS/FLI1. It is widely known that Ewing sarcoma cells depend on the transcript
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::31b18dcfa115768255d6318f4469f565
https://doi.org/10.1158/1538-7445.am2014-3962
https://doi.org/10.1158/1538-7445.am2014-3962
Autor:
Muñoz-Alonso, María J., Álvarez, Enrique, Guillén-Navarro, María José, Pollán, Marina, Avilés, Pablo, Galmarini, Carlos M., Muñoz, Alberto
Publikováno v:
Marine Drugs; Jun2013, Vol. 11 Issue 6, Special section p1677-1692, 21p
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Leal, Juan F.M.1, García-Hernández, Verónica2, Moneo, Victoria1, Domingo, Alberto2, Bueren-Calabuig, Juan Antonio3, Negri, Ana3, Gago, Federico3, Guillén-Navarro, María José1, Avilés, Pablo1, Cuevas, Carmen1, García-Fernández, Luis Francisco1, Galmarini, Carlos María1 cgalmarini@pharmamar.com
Publikováno v:
Biochemical Pharmacology. Jul2009, Vol. 78 Issue 2, p162-170. 9p.